Mcl-1 is an antiapoptotic, B-cell lymphoma (BCL)-2 family protein whose high expression has been associated with increased cancer cell survival that translates to chemotherapy resistance and poor patient prognoses17,18. This evidence concerns the gene MCL1 and cancer.